EP1942805A2 - Systeme radiographique destine a la creation de representations radiographiques par application d'agents de contraste - Google Patents
Systeme radiographique destine a la creation de representations radiographiques par application d'agents de contrasteInfo
- Publication number
- EP1942805A2 EP1942805A2 EP06807524A EP06807524A EP1942805A2 EP 1942805 A2 EP1942805 A2 EP 1942805A2 EP 06807524 A EP06807524 A EP 06807524A EP 06807524 A EP06807524 A EP 06807524A EP 1942805 A2 EP1942805 A2 EP 1942805A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- contrast
- ray
- radiation
- patient
- ray system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000002872 contrast media Substances 0.000 title claims abstract description 143
- 229940039231 contrast media Drugs 0.000 title abstract description 13
- 230000005855 radiation Effects 0.000 claims abstract description 70
- 238000001228 spectrum Methods 0.000 claims abstract description 49
- 238000000034 method Methods 0.000 claims abstract description 34
- 229910052747 lanthanoid Inorganic materials 0.000 claims abstract description 18
- 150000002602 lanthanoids Chemical class 0.000 claims abstract description 18
- 238000004088 simulation Methods 0.000 claims description 27
- 229910052688 Gadolinium Inorganic materials 0.000 claims description 17
- 229910052740 iodine Inorganic materials 0.000 claims description 17
- 229910052691 Erbium Inorganic materials 0.000 claims description 15
- 229910052692 Dysprosium Inorganic materials 0.000 claims description 14
- 229910052689 Holmium Inorganic materials 0.000 claims description 14
- 229910052775 Thulium Inorganic materials 0.000 claims description 14
- 238000010521 absorption reaction Methods 0.000 claims description 14
- 229910052769 Ytterbium Inorganic materials 0.000 claims description 13
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 10
- 229910052772 Samarium Inorganic materials 0.000 claims description 10
- 239000011630 iodine Substances 0.000 claims description 10
- 229910052779 Neodymium Inorganic materials 0.000 claims description 9
- 229910052777 Praseodymium Inorganic materials 0.000 claims description 9
- 229910052771 Terbium Inorganic materials 0.000 claims description 9
- 229910052746 lanthanum Inorganic materials 0.000 claims description 9
- 229910052684 Cerium Inorganic materials 0.000 claims description 8
- 229910052693 Europium Inorganic materials 0.000 claims description 8
- 238000004590 computer program Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 229910052765 Lutetium Inorganic materials 0.000 claims description 7
- 238000002083 X-ray spectrum Methods 0.000 claims description 5
- 210000000746 body region Anatomy 0.000 claims description 5
- 238000011835 investigation Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 210000004072 lung Anatomy 0.000 claims description 4
- 238000005259 measurement Methods 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 230000005540 biological transmission Effects 0.000 claims description 3
- 229910052797 bismuth Inorganic materials 0.000 claims description 3
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000012360 testing method Methods 0.000 claims description 3
- 238000011068 loading method Methods 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 239000004744 fabric Substances 0.000 claims 1
- 238000003384 imaging method Methods 0.000 claims 1
- 230000003313 weakening effect Effects 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000001133 acceleration Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 9
- ZPDFIIGFYAHNSK-UHFFFAOYSA-K gadobutrol Chemical compound [Gd+3].OCC(O)C(CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-UHFFFAOYSA-K 0.000 description 8
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 8
- 210000000709 aorta Anatomy 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 230000006399 behavior Effects 0.000 description 4
- 238000002591 computed tomography Methods 0.000 description 4
- DGAIEPBNLOQYER-UHFFFAOYSA-N iopromide Chemical compound COCC(=O)NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)N(C)CC(O)CO)=C1I DGAIEPBNLOQYER-UHFFFAOYSA-N 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- ZPDFIIGFYAHNSK-CTHHTMFSSA-K 2-[4,10-bis(carboxylatomethyl)-7-[(2r,3s)-1,3,4-trihydroxybutan-2-yl]-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+) Chemical compound [Gd+3].OC[C@@H](O)[C@@H](CO)N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1 ZPDFIIGFYAHNSK-CTHHTMFSSA-K 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000002583 angiography Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000013065 commercial product Substances 0.000 description 2
- 150000004696 coordination complex Chemical class 0.000 description 2
- 230000000254 damaging effect Effects 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229960003411 gadobutrol Drugs 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 241001136792 Alle Species 0.000 description 1
- 230000005461 Bremsstrahlung Effects 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- 208000010513 Stupor Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 235000019994 cava Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- KBQHZAAAGSGFKK-UHFFFAOYSA-N dysprosium atom Chemical compound [Dy] KBQHZAAAGSGFKK-UHFFFAOYSA-N 0.000 description 1
- UYAHIZSMUZPPFV-UHFFFAOYSA-N erbium Chemical compound [Er] UYAHIZSMUZPPFV-UHFFFAOYSA-N 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000013213 extrapolation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- OCDAWJYGVOLXGZ-VPVMAENOSA-K gadobenate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)C(C([O-])=O)COCC1=CC=CC=C1 OCDAWJYGVOLXGZ-VPVMAENOSA-K 0.000 description 1
- HZHFFEYYPYZMNU-UHFFFAOYSA-K gadodiamide Chemical compound [Gd+3].CNC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC(=O)NC HZHFFEYYPYZMNU-UHFFFAOYSA-K 0.000 description 1
- PIZALBORPSCYJU-QSQMUHTISA-H gadofosveset Chemical compound O.[Na+].[Na+].[Na+].[Gd+3].C1CC(OP([O-])(=O)OC[C@@H](CN(CCN(CC([O-])=O)CC([O-])=O)CC(=O)[O-])N(CC([O-])=O)CC([O-])=O)CCC1(C=1C=CC=CC=1)C1=CC=CC=C1 PIZALBORPSCYJU-QSQMUHTISA-H 0.000 description 1
- LGMLJQFQKXPRGA-VPVMAENOSA-K gadopentetate dimeglumine Chemical compound [Gd+3].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O LGMLJQFQKXPRGA-VPVMAENOSA-K 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- KJZYNXUDTRRSPN-UHFFFAOYSA-N holmium atom Chemical compound [Ho] KJZYNXUDTRRSPN-UHFFFAOYSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- VCMGMSHEPQENPE-UHFFFAOYSA-N ketamine hydrochloride Chemical compound [Cl-].C=1C=CC=C(Cl)C=1C1([NH2+]C)CCCCC1=O VCMGMSHEPQENPE-UHFFFAOYSA-N 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- OHSVLFRHMCKCQY-UHFFFAOYSA-N lutetium atom Chemical compound [Lu] OHSVLFRHMCKCQY-UHFFFAOYSA-N 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- QEFYFXOXNSNQGX-UHFFFAOYSA-N neodymium atom Chemical compound [Nd] QEFYFXOXNSNQGX-UHFFFAOYSA-N 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- PUDIUYLPXJFUGB-UHFFFAOYSA-N praseodymium atom Chemical compound [Pr] PUDIUYLPXJFUGB-UHFFFAOYSA-N 0.000 description 1
- 238000011555 rabbit model Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229940069575 rompun Drugs 0.000 description 1
- KZUNJOHGWZRPMI-UHFFFAOYSA-N samarium atom Chemical compound [Sm] KZUNJOHGWZRPMI-UHFFFAOYSA-N 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000003325 tomography Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- QYEFBJRXKKSABU-UHFFFAOYSA-N xylazine hydrochloride Chemical compound Cl.CC1=CC=CC(C)=C1NC1=NCCCS1 QYEFBJRXKKSABU-UHFFFAOYSA-N 0.000 description 1
- NAWDYIZEMPQZHO-UHFFFAOYSA-N ytterbium Chemical compound [Yb] NAWDYIZEMPQZHO-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/482—Diagnostic techniques involving multiple energy imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/488—Diagnostic techniques involving pre-scan acquisition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/50—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications
- A61B6/504—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment specially adapted for specific body parts; specially adapted for specific clinical applications for diagnosis of blood vessels, e.g. by angiography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/54—Control of apparatus or devices for radiation diagnosis
- A61B6/542—Control of apparatus or devices for radiation diagnosis involving control of exposure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/54—Control of apparatus or devices for radiation diagnosis
- A61B6/545—Control of apparatus or devices for radiation diagnosis involving automatic set-up of acquisition parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1075—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions by non-invasive methods, e.g. for determining thickness of tissue layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/06—Diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
- A61B6/4007—Arrangements for generating radiation specially adapted for radiation diagnosis characterised by using a plurality of source units
- A61B6/4014—Arrangements for generating radiation specially adapted for radiation diagnosis characterised by using a plurality of source units arranged in multiple source-detector units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
- A61B6/4035—Arrangements for generating radiation specially adapted for radiation diagnosis the source being combined with a filter or grating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
- A61B6/4241—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using energy resolving detectors, e.g. photon counting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
- A61B6/4266—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a plurality of detector units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/44—Constructional features of apparatus for radiation diagnosis
- A61B6/4429—Constructional features of apparatus for radiation diagnosis related to the mounting of source units and detector units
- A61B6/4435—Constructional features of apparatus for radiation diagnosis related to the mounting of source units and detector units the source unit and the detector unit being coupled by a rigid structure
- A61B6/4441—Constructional features of apparatus for radiation diagnosis related to the mounting of source units and detector units the source unit and the detector unit being coupled by a rigid structure the rigid structure being a C-arm or U-arm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/58—Testing, adjusting or calibrating thereof
- A61B6/582—Calibration
- A61B6/583—Calibration using calibration phantoms
Definitions
- the invention relates to an X-ray system for generating diagnostic X-ray images of a patient with an X-ray tube, a detector, a Kontraststoffapplikati ⁇ onshim and a control and processing unit, wherein the X-ray system has a possibility for selecting different operating parameters at least with respect to the energy spectrum of the X-ray radiation used.
- the invention also relates to a method for optimizing to-mographischer representations of a patient by X-rays with an energy spectrum to be selected and measurement of the attenuation of the X-ray radiation when passing through the patient in different solid angles with additional administration of contrast agent for contrast enhancement in the tomographic presentation.
- the invention relates to the use of a lanthanide-containing complex for producing a contrast agent for diagnostic support in an X-ray examination.
- contrast media are often applied to produce a high-contrast representation, which either attaches to specific body structures, eg carcinomas, or enriches certain bodily fluids, eg, blood.
- Such contrast agents usually contain elements which are distinguished by high absorption coefficients and thus provide a good contrast to the surrounding tissue with a relatively low absorption coefficient.
- iodine-containing contrast agents Because of any existing incompatibilities of the examined patient with iodine, gadolinium-containing contrast agents are also used. In this context, are generally lanthanide-containing
- Contrast agents proposed. It is in this regard, for example ⁇ , to the headings "Arterial angiography in high kilovol- day technique with gadolinium as the contrast agent: first clinical experience", F. Fobbe et al, Eur Radiol 6, 224- 229 (1996)... , Springer-Verlag; "Evaluation of Gadobutrol in a Rabbit Model as a New Lanthanide Contrast Agent for Computer Tomography", Stephan A. Schmitz et al. , Investigative Radiolgy, Vol.
- the inventors have recognized that it is not enough for it ⁇ submission of an optimum contrast-to-noise ratio easy to select a contrast agent is busy with the highest possible atomic number which ment with a EIe-. Rather, it has been found that, depending on the particular area of the patient examined, an optimal combination of contrast agent and the energy spectrum of the X-ray radiation used for the examination is necessary.
- the ge coherences between absorption and energy spectrum of the radiation, taking into account an optimum contrast-to-noise ratio at the respective predetermined Letsbe ⁇ rich in patient are relatively complex and can not in simple rules or formulas reflect.
- these parameters can also be considered in the examined tissue environment.
- Different tissue environments Exercises such as bone, heart, liver or brain also cause differences in the selection of the optimal contrast agent / energy spectrum combination due to the different absorption behavior of the respective tissue.
- the choice can not relate only to the difference ⁇ contrast-generating elements or different contrast agents, but it can also be differences regarding the optimal chemical structure of the contrast medium necessary.
- a contrast medium ⁇ which only accumulate in the blood stream and is intended to degrade later
- another molecule be used as a contrast agent in which a marker is to be attached to structures in the form carcinogenic. It is also possible for combinations of both variants to be selected for optimal recognition in an X-ray representation.
- the concentration of the contrast medium can be gen as an indication or the compatibility of the respective contrast agent herangezo ⁇ their application concentration.
- different contrast agents and for selecting the optimum contrast agent / radiation combination can then be used in accordance with normalized contrast mediums telkonzentrationen.
- a spectrum-dependent radiation damage factor can also be incorporated here, since in principle it can be assumed that higher-energy X-ray radiation is less damaging than low-energy radiation.
- the optimization ⁇ refers tion always expressed the contrast-to-noise ratio in the same dose of radiation or otherwise, it is the optimum choice of a contrast agent, which is the best contrast-to-noise ratio obtained by setting a BE ⁇ agreed contrast to noise ratio in the image mini ⁇ tion of the dose used so the radiation exposure of the examined patient reached.
- Contrast-to-noise ratio on by increasing the concentra ⁇ a contrast agent can be achieved, on the other hand the patient for reasons of compatibility should not be burdened with too ho ⁇ hen contrast agent doses.
- the combination of contrast agent and X-ray radiation is found, which is normalized to the radiation dose used or better normalized to its damaging effect and standardized to the concentration of the contrast agent or better its compatibility the best contrast-to-noise ratio. are, then taking place on the basis of these determined contrast mediums / radiation combination, the CT examination under a minimized dose and contrast agent concentration, so that a sufficiently high contrast for the clinical evaluation image can be reconstructed.
- an X-ray system for generating diagnostic X-ray images of a patient, preferably an X-ray system with at least one X-ray tube for generating a beam of X-rays with an energy ⁇ spectrum for scanning the patient, a detector for measuring the attenuation of X-rays during passage through the patient, an application unit for the administration of contrast agent for contrast enhancement in the tomographic view of the patient, a control and processing unit for controlling the X-ray system andVaccinel ⁇ the X-ray images and lung of the patient with the aid of stored and executed computer programs, wherein the X-ray system has a possibility of selecting different operating parameters at least with regard to the energy spectrum of the X-ray radiation used, this X-ray system having a selecting means wel ⁇ ches by the direct or indirect indication of the parameter examination volume on the one hand and investigated Gewe- be Modell the other hand, at least one combination of contrast and energy spectrum of the X-ray radiation predetermines for the
- the selection means itself will generally be realized by computer programs in conjunction with an input keyboard and a display unit. Basically, it is also within the scope of the invention, when specific keys are optionally associated with specially ⁇ len ads, provided at the X-ray system. It is essential for the invention that the surgeon appropriate means is provided, whereby he can pass on the necessary specifications to the system.
- This selection means now makes it possible for the surgeon to find the optimum combination of contrast agent to be used and energy spectrum by simply specifying a body region to be examined or the tissue structure to be examined.
- the selection means having a look-up table in which, depending on the body region to be examined or the tissue structure to be examined, optimum combinations of contrast agent and energy spectrum of the X-ray radiation to be used are stored.
- the selecting means may be additionally connected to the control of the X-ray system, so that by the selection of Ope ⁇ rateurs if this results in a clear choice of optimum Kon medium and energy spectrum, automatically results in a corresponding adjustment of the X-ray system with respect to the tube voltage used and / or a filter to use for the radiation. If several equivalent solutions are available, these can be offered to the surgeon for further selection.
- the detector in differing ⁇ chen modes of operation, as an integral detector to operate event-counting detector or energy-specific detector, the optimal choice may be dictated by the teldatemit-. Because even by different modes of operation of the detector, the optimal choice of contrast agent / energy spectrum combination can be influenced.
- both integrating and event counting can be detected in these energy ranges, wherein the at least one limit value between the detected energy ranges is variable is.
- the selection means may be connected to a controller that limit it and this limit entspre ⁇ accordingly optimal with respect to the best set ratio contrast-to-noise ratio.
- the inventors also suggest that an indirect input possibility for the examination volume by specifying the body region is provided in the X-ray system ,
- the indication of the examination regions of the head, thorax or abdomen already provides a largely good approximation for these values.
- the proposed X-ray system can be both a system for producing transmission images and an X-ray system for producing tomographic representations, ie a CT or a C-arm device with means for the reconstruction of tomographic images, wherein the preferred application in the tomographic systems.
- an X-ray system for generating tomographic representations the X-ray tube (s) and possibly the one or more detectors rotatably mounted around the patient, so that a plurality of projections from different projection directions can be recorded.
- CT images are provided, said means usually consist of egg ⁇ ner combination of computing unit and corresponding computer programs.
- the contrast to be able to optimize contrast agents are made available ⁇ noise ratio, comprising at least one contrast agent complex, and as a contrast material include a selection of at least two contrast-producing elements from the list below: I, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, Lu, Bi; preferably Dy, Ho, Er, Tm, Yb or Lu.
- the inventors propose a method for optimizing tomographic representations of a patient by X-rays with an energy spectrum to be selected and measuring the attenuation of the X-ray radiation when passing through the patient at different solid angles with additional administration of contrast agent to improve the contrast in the tomographic display prior to the examination for the CT system, determining the contrast-to-noise ratio of different energy spectra of the X-ray and different contrast agents relative to tissue-like material or tissue and before examining a patient on the basis of the X-ray system an optimized selection of at least one contrast agent / X-ray spectrum combination is made available to a given examination region of the patient, which provides an optimal contrast-to-noise ratio in the examination b area allows.
- According to the invention can be to select a look-up table USAGE ⁇ det, in the function of the predetermined sec ⁇ monitoring region of the patient at least one optimal combination nation of contrast medium is stored to the energy spectrum of the X-ray radiation to be used.
- the Letsbe- can even after a prescan rich, optionally ren with different Energyspekt ⁇ , on the basis of the actual present absorption values in the examination zone by means of simulation with different available contrast agents and energy spectra, optionally also detectors relational as detector modes, the optimal combination of Contrast means and used for scanning energy ⁇ spectrum of the X-ray radiation can be determined.
- the tube voltage can also be set automatically after the selection of the contrast agent initiated by the surgeon and / or the energy spectrum of the X-ray radiation used can be automatically adjusted by filtering according to previously stored or calculated information.
- an energy-specific detection of at least two energy ranges may, however, depending on the energy integ ⁇ be detected rierend separated, wherein the at least one limit switch ⁇ value variable between the detected energy ranges adjustable and the control of this limit value entspre ⁇ accordingly the selection made by the operator and existing Defaults depending on the contrast agent used and the energy spectrum of the X-radiation takes place.
- At least two energy ranges can separates ge ⁇ and detected event counting, said ranging min ⁇ least a limit value between the detected Energybe ⁇ is variably adjustable and the control of this Limit value corresponding to the choice made by the surgeon and existing specifications depending on the contrast agent used and the energy spectrum of the X-ray radiation.
- a measure for the patient volume, ie for the cross section of the patient to be examined, to be penetrated by the radiation can be entered directly or indirectly for selecting the optimal combination of contrast agent and energy spectrum.
- a look-up table can be used which, from other information, includes the actual patient volume or the cross section to be penetrated.
- the patient volume can be determined and, preferably automatically, transferred to the X-ray system. Accordingly, the patient volume can also be optically determined.
- the weight preferably by a weighing device in the patient table, so that there is a, usually additional parameter for estimating the cross section of the patient in the examination area.
- a pre-scan can be used, and it is thus possible simultaneously to make approximate absorption provisions without contrast to using this information and Simulati ⁇ onsticianen with contrast even better the optimal combination of einbydem contrast medium and energy spectrum predetermine and, if appropriate, to automatically take over the X-ray system and to configure it accordingly.
- the inventive method may be similar to the previously signed ⁇ X-ray system for both the production and presentation Position of transmission recordings are used as for the representation of tomographic images by corresponding and per se known reconstruction steps.
- contrast agents made available to be provided according to the invention at least two contrast media with un ⁇ teretzlichen contrast-producing elements for selection, wherein the elements from the following list I, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho , Er, Tm, Yb, Lu, Bi, preferably selected from the list Dy, Ho, Er, Tm, Yb, Lu.
- An example of this would be a set of contrast agents with the contrast generating elements I, Sm and Er. In principle, however, it should be noted that a higher number of different contrast agents also permits a more optimized selection.
- the contrast media available for selection can also be mixed, so that different contrast agent mixtures with different complexes are used.
- the list of elements used remains the same.
- contrast agents which have different contrast-forming elements in chemical bonding.
- a contrast agent can have a complex with one La and one Gd atom or two complexes with one La and one Gd atom each. It thereby becomes the mixing ratio fixed, so that a change in the mixing ratio can not arise due to application problems.
- Example ⁇ example can also by 3 chemically bound contrast-forming elements fixed mixing ratios of 1: 2 at different two elements, or 1: 1: be achieved at three different elements.
- a lanthanide com- plex for the preparation of a contrast agent for diagnostic assistance in a CT examination to use, wherein depending on the cross section and the weave structure of the examination ⁇ range, such a combination of a lanthanide for the contrast agent and an energy spectrum of the X-radiation used is selected which produces a maximum contrast-to-noise ratio in a CT representation.
- the fol ⁇ constricting reference numerals are used: 1: CT system; 2: first X-ray tube; 3: first detector; 4: second X-ray tube; 5: second detector; 6: gantry housing; 7: patient; 8: patient couch; 9: system axis; 10: control and computing unit; 11: memory; 12: contrast agent applicator; 13: temporal contrast course; 14: aorta abdominalis; Prg x : computer programs.
- FIG. 1 CT system with contrast agent injector
- FIG. 3 Simulation values of contrast-to-noise
- FIG 6 Simulation values from FIG 5 as applied to the same dose normalized with respect mass equivalents contrast-to-noise ratio of the contrast agent; 7 shows simulation values of the contrast-to-noise ratio
- FIG 8 shows simulation values of FIG 7 as a contrast-to-noise applied to the same dose normalized with respect mass equivalents ratio of the contrast agent
- FIG 9 shows simulation values of Figure 3 with a cylindrical phantom of 20 cm diameter
- FIG 10 shows simulation values of Figure 3 with a cylindrical phantom of 30 cm diameter
- 11 shows simulation values of Figure 3 with a cylindrical phantom of 40 cm diameter
- FIG. 12 Simulation values of the contrast-to-noise ratio
- FIG. 14 Time course of the ⁇ HU values in the aorta from FIG. 13;
- FIG 15 To same dose normalized mass equivalents contrast-to-noise ratio of voltage against tubes ⁇ , celiac in aorta.
- the inventive CT system can be in its basic structure, for example, a conventional CT system having a single focus / detector system to act, wherein the X-ray tube used influencing at least the possibility of Be ⁇ has the energy spectrum of X-ray radiation used. This can be done for example by controlling the acceleration voltage or the insertion of filters in the beam path.
- Such systems are well known.
- the selection means described in more detail later are additionally integrated as an additional component.
- a dual or multiple focus / detector system As shown in FIG.
- a CT system 1 has a first X-ray tube 2 with an opposite detector 3 and a second X-ray tube 4 with a further, opposite detector 5.
- Both focus / detector systems 2, 3 and 4, 5 are in a gantry housing 6 one to a system axis 9 rotating and not shown here, gantry ordered ⁇ .
- the patient 7 is situated at an lekssver ⁇ slidable patient table 8 which is pushed to scan the patient 7 during the rotation of the focus / detector systems kontinuier ⁇ Lich or stepwise through an opening in the gantry. 6 As a result, the patient 7 is scanned spirally or repeatedly in a circle.
- a contrast agent is applied to the patient 7 to improve the contrast of a CT image reconstructed from the detector output data.
- This can be done, for example, by a contrast agent injector 12, which injects the selected contrast agent into the patient 7 with a predetermined flow, possibly also with time-dependent variation.
- the contrast agent may be designed for a cardio examination so that after the injection it remains exclusively in the bloodstream before it is degraded.
- a very good representation of the bloodstreams and corresponding clinical reviews are possible.
- this tumor is strongly highlighted in CT examination and thus easily diagnosed or determined in its location and extent.
- combinations of both previously described variants possible in which case preferably different contrast-forming elements used who ⁇ can, which can be displayed separately due to their energy-specific difference ⁇ absorption behavior.
- control and processing unit 10 has a memory 11, in which in addition to the measured detector output data and computer programs Prgi-prg n are stored, which are executed ⁇ out in operation and essentially take over the control of the system and the evaluation of the data.
- ⁇ selection means in this preferred embodiment of a CT 's present in the form of a computer program Prg x in the control and computing unit 10th The necessary inputs to the selection means, such as patient diameter or examination area, can be made via the keyboard.
- the outputs of the selection means to the surgeon in the form of the optimal to be selected contrast agent / radiation combination can be done on the screen. Alternatively, this combination can also be passed on to the computer and fed directly into the controller.
- System offers various advantages over a conventional CT system. For example, different two or more detectors with different lent operating modes are used, if not detectors are available, which are switchable with the same structure in different operating modes. Detector system, a prescan or also the actual scan are carried out, each with a different energy spectrum gleichzei ⁇ tig with each focus /. Likewise, a simple simultaneous on ⁇ 's takeover of several tomograms to determine the patient's dimensions possible, which later optimum selection of the right contrast agent / facilitate radiation combination.
- the contrast-generating elements are plotted in this figure 2 from left to right with increasing atomic number.
- the results show that, first with increasing ordinal number ⁇ an improvement therefore increase the contrast-to-noise ratio can be observed. It will be a small plateau reaches the contrast-to-noise ratio in the contrast ⁇ form the elements Er and Tm, followed by a unsteti ⁇ gen drop of the contrast-to-noise ratio to Bi.
- the elements provide Tb to Bi at 10OkV accelerating voltage a maximum value for the contrast-to-noise ratio, currency ⁇ rend the minimum value at Tb to Ho through 140 kV radiation in He to Lu through 80 kV radiation and Bi by 100kV Radiation is generated.
- this simulation values of Figure 3 are still ⁇ times than the same dose normalized mass equivalents con- contrast-to-noise ratio plotted against the elements. Basically, it is a re-normalization of the curves of FIG. 3. These curves illustrate that, for example, in the range of I to Sm, the use of lower acceleration voltages and higher order contrasting elements leads to a reduction in the necessary contrast agent concentration for the same contrast-to Noise ratio leads. However, this statement is no longer transferable for further increasing atomic number.
- FIG. 5 shows the simulation values of the contrast-to-noise ratio of various contrast agents with different elements against water, using the two acceleration voltages 8OkV and 12OkV, respectively with and without beam hardening by copper filters.
- the influence of the filtering is greater in the 80kV radiation than in the 120kV radiation. Since the same filter thickness was used for both radiations, the effect of beam hardening was also relatively stronger with the 80 kV radiation than with the 120 kV radiation.
- Contrast-to-noise ratio of various contrast agents applied Another effect which influences the behavior of the contrast-to-noise ratios of different contrast agents zueinan ⁇ at different radiation is the operating mode of the detector used. 7 shows the simulation values of the contrast-to-noise ratio diver ⁇ ser contrast agents with different contrast-forming elements against water with a X-ray radiation for four different detectors with different Radiomo ⁇ mode. Results are compared with a simple energy-integrating detector, an event-counting detector, an energy-specific event-counting detector with two energy ranges and an energy-specific event-counting detector with energy ranges in the 5keV range.
- FIG. 9 the simulation values according to FIG. 3 with a cylindrical phantom with diameters of 20 cm are shown in FIGS. 9 to 11. 30cm and 40cm, where centrally in the phantom a small contrast medium-filled cylinder is arranged.
- FIGS. 9 to 10 the simulation results for each of four different X-ray radiations with 80, 100, 120 and 140 kV acceleration voltage are shown.
- FIG. 11 corresponds identically to FIG. 3.
- results of Si ⁇ mulations are, but which can be equally replaced by direct measurements.
- results shown were all determined against a water environment. If a further improved selection and coordination of the contrast agents and their combination with radiation variants and / or detector variants is to be determined, it is better to record these measured values compared to actual tissue structures, since further differentiations are also possible due to different environments for the contrast agent.
- experimental studies have been conducted in animals to compare the contrast agent gadolinium component using the contrast agent Gadovist® and Kontraststoffponen ⁇ te iodine using the contrast agent Ultravist.
- G2 Gadovist lmol Gd / kg KM (157 mg Gd / kg KM)
- G3 Gadovist 2 mol Gd / kg KM (314 mg Gd / kg KM)
- G4 Gadovist estimate how much is necessary to achieve the same ⁇ HU in the vessels, here the aorta.
- the measurement protocol should allow angiography of the large abdominal vessels (aorta, cava, v. Portae) and a kidney ⁇ presentation to generate (human protocol: abdomen standard). Over 8 minutes, the animals are scanned closely.
- ⁇ HU values HU values minus baseline value in the abdominal vessels and the kidneys were determined at different tube voltages. For the established protocol, an extrapolation of the administered radiation dose was made. At- closing was estimated that dose reduction may allow the on ⁇ rate of gadolinium significant picture quality.
- a sample recording of a scan is in the figure 13 Darge ⁇ .
- gadolinium has been shown in vivo that nen for clinically relevant tube voltages lanthanides ei ⁇ higher CT contrast reach as iodine.
- a CT system with a selection agent for the best combination of Kon medium and energy spectrum of X-rays used to scan to optimize is the noise-to-contrast-comparison holds isses, a method for generating CT images with so by this invention Assistance of contrast agents taking into account an optimal combination of contrast medium and energy spectrum of an X-radiation used for the scan and the use of The use of a lanthanide-containing complex for producing a contrast agent for optimizing the combination of contrast agent and radiation to achieve a maximum contrast-to-noise ratio in a CT display suggested.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medical Informatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Optics & Photonics (AREA)
- Radiology & Medical Imaging (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- High Energy & Nuclear Physics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Dentistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005052368.4A DE102005052368B4 (de) | 2005-10-31 | 2005-10-31 | Röntgensystem zur Erstellung diagnostischer Röntgendarstellungen unter Applikation von Kontrastmitteln |
PCT/EP2006/067741 WO2007051739A2 (fr) | 2005-10-31 | 2006-10-25 | Systeme radiographique destine a la creation de representations radiographiques par application d'agents de contraste |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1942805A2 true EP1942805A2 (fr) | 2008-07-16 |
Family
ID=37680754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP06807524A Withdrawn EP1942805A2 (fr) | 2005-10-31 | 2006-10-25 | Systeme radiographique destine a la creation de representations radiographiques par application d'agents de contraste |
Country Status (4)
Country | Link |
---|---|
US (1) | US7695193B2 (fr) |
EP (1) | EP1942805A2 (fr) |
DE (1) | DE102005052368B4 (fr) |
WO (1) | WO2007051739A2 (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102007024158B4 (de) | 2007-05-24 | 2017-09-14 | Bayer Intellectual Property Gmbh | Auswahlverfahren für zwei Kontrastmittel zur Verwendung in einer Dual-Energy-CT-Untersuchung, Kontrastmittelkombination und Erzeugung von CT-Aufnahmen mit einer Kontrastmittelkombination mit unterschiedlichen Energiespektren |
US20130116554A1 (en) | 2010-07-12 | 2013-05-09 | Ge Healthcare As | X-ray imaging at low contrast agent concentrations and/or low dose radiation |
DE102010043712B4 (de) * | 2010-11-10 | 2021-03-18 | Siemens Healthcare Gmbh | Verfahren zur Ermittlung des Wertes einer Röhrenspannung, Röntgeneinrichtung, Rechenprogramm und Datenträger |
US9693742B2 (en) * | 2011-01-18 | 2017-07-04 | Siemens Aktiengesellschaft | Method for generating a contrast medium-assisted X-ray image and X-ray system |
US9198633B2 (en) | 2011-07-29 | 2015-12-01 | Gammex, Inc. | Computed tomography perfusion phantom and method use thereof |
WO2013047439A1 (fr) * | 2011-09-27 | 2013-04-04 | 株式会社 日立メディコ | Dispositif de tomodensitométrie et procédé de correction d'image |
WO2013104690A1 (fr) | 2012-01-11 | 2013-07-18 | Ge Healthcare As | Milieux de contraste radiologiques à basse concentration d'iode et processus de radiologie |
WO2015018605A1 (fr) | 2013-08-08 | 2015-02-12 | Sony Corporation | Réseau de communication mobile, dispositif de communication et procédés |
DE102013220665A1 (de) * | 2013-10-14 | 2015-04-16 | Siemens Aktiengesellschaft | Bestimmung eines Werts eines Aufnahmeparameters mittels einer anatomischen Landmarke |
DE102014203465A1 (de) * | 2014-02-26 | 2015-08-27 | Siemens Aktiengesellschaft | Verfahren zur Auswahl eines Strahlungsformfilters und Röntgenbildgebungssystem |
DE102014203463B3 (de) | 2014-02-26 | 2015-07-09 | Siemens Aktiengesellschaft | Patientenabhängige Optimierung der Kontrastmittelmenge |
WO2015195501A1 (fr) * | 2014-06-17 | 2015-12-23 | University Of Massachusetts Medical School | Tomodensitogrammes utilisant un produit de contraste à base de gadolinium |
DE102015202999B4 (de) * | 2015-02-19 | 2019-12-05 | Siemens Healthcare Gmbh | Automatisierte Justierung von Signalanalyseparametern für Röntgendetektoren |
US10561391B2 (en) * | 2016-08-18 | 2020-02-18 | General Electric Company | Methods and systems for computed tomography |
JP6670509B2 (ja) * | 2017-01-20 | 2020-03-25 | 台達電子工業股▲ふん▼有限公司Delta Electronics,Inc. | コンピュータ断層撮像システムの造影方法 |
TWM553128U (zh) * | 2017-01-20 | 2017-12-21 | 台達電子工業股份有限公司 | 動物載床 |
US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
WO2019207078A1 (fr) * | 2018-04-25 | 2019-10-31 | Ge Healthcare As | Détection et quantification de dépôt de gadolinium |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3848130A (en) * | 1973-06-25 | 1974-11-12 | A Macovski | Selective material x-ray imaging system |
US4160906A (en) * | 1977-06-23 | 1979-07-10 | General Electric Company | Anatomically coordinated user dominated programmer for diagnostic x-ray apparatus |
US5687208A (en) * | 1995-10-06 | 1997-11-11 | Bhb General Partnership | Method of and apparatus for predicting computed tomography contrast enhancement with feedback |
JP4702999B2 (ja) * | 2000-12-13 | 2011-06-15 | 株式会社東芝 | 診断システム |
US20050053551A1 (en) * | 2003-09-08 | 2005-03-10 | Badiola Carlos M. | Use of a combination of gadolinium-based contrast media and iodinated contrast media as a contrast agent for X-ray based medical imaging procedures |
US7672431B2 (en) * | 2003-10-10 | 2010-03-02 | Bayer Schering Pharma Aktiengesellschaft | X-ray arrangement and x-ray contrast process for imaging an object under examination that contains at least one radiopaque element as well as use of the x-ray arrangement |
DE10347961A1 (de) * | 2003-10-10 | 2005-06-09 | Schering Ag | Röntgenanordnung und Röntgenkontrastverfahren zur Bildgebung an einem mindestens ein röntgenkontrastgebendes Element enthaltenden Untersuchungsobjekt sowie Verwendung der Röntgenanordnung |
US7869862B2 (en) * | 2003-10-15 | 2011-01-11 | Varian Medical Systems, Inc. | Systems and methods for functional imaging using contrast-enhanced multiple-energy computed tomography |
DE102004003371B4 (de) * | 2004-01-22 | 2012-08-30 | Siemens Ag | Verfahren zum Betrieb eines Computertomographen und eines Injektors sowie Vorrichtung mit einem Computertomographen und einem Injektor |
DE102004004626A1 (de) * | 2004-01-29 | 2005-08-25 | Siemens Ag | Vorrichtung und Verfahren zur Aufnahme eines Hochenergiebilds |
-
2005
- 2005-10-31 DE DE102005052368.4A patent/DE102005052368B4/de active Active
-
2006
- 2006-10-25 WO PCT/EP2006/067741 patent/WO2007051739A2/fr active Application Filing
- 2006-10-25 EP EP06807524A patent/EP1942805A2/fr not_active Withdrawn
- 2006-10-25 US US12/084,259 patent/US7695193B2/en active Active
Non-Patent Citations (1)
Title |
---|
See references of WO2007051739A2 * |
Also Published As
Publication number | Publication date |
---|---|
US7695193B2 (en) | 2010-04-13 |
US20080310582A1 (en) | 2008-12-18 |
WO2007051739A2 (fr) | 2007-05-10 |
WO2007051739A3 (fr) | 2007-06-21 |
DE102005052368A1 (de) | 2007-05-16 |
DE102005052368B4 (de) | 2015-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007051739A2 (fr) | Systeme radiographique destine a la creation de representations radiographiques par application d'agents de contraste | |
DE69313148T2 (de) | Röntgenologischer Bilddarstellungsapparat | |
EP2150179B1 (fr) | Procédé de sélection de deux agents de contraste destinés à être utilisés lors d'un examen par ct à double énergie, combinaison d'agents de contraste et production d'images de ct à l'aide d'une combinaison d'agents de contraste et de spectres d'énergie différents | |
DE102014203463B3 (de) | Patientenabhängige Optimierung der Kontrastmittelmenge | |
DE102011004120B4 (de) | Verfahren, Bilddatensatzbearbeitungseinrichtung, Röntgensystem und Computerprogramm zur Korrektur von Bilddaten eines Untersuchungsobjekts | |
DE102010027227B4 (de) | Verfahren und Computertomographiegerät zur Durchführung einer angiographischen Untersuchung | |
DE102004004295A1 (de) | Verfahren zur Bilddatenaufnahme und -auswertung mit einem Tomographiegerät | |
WO2012097801A1 (fr) | Procédé de production d'une représentation radiographique assistée par agent de contraste et système radiographique approprié | |
DE19950794A1 (de) | Röntgeneinrichtung und Verfahren zur Beeinflussung von Röntgenstrahlung | |
DE102018212389B3 (de) | Verfahren zum Betrieb einer Röntgeneinrichtung, Röntgeneinrichtung, Computerprogramm und elektronisch lesbares Speichermedium | |
DE102012215922B4 (de) | Medizintechnische Anlage und Verfahren zur Erzeugung von Bildern | |
DE102004020861B4 (de) | Verfahren zur Rekonstruktion von Projektionsdatensätzen bei Dosis-reduzierter abschnittsweiser spiralförmiger Abtastung in der Computertomographie | |
EP1890604A1 (fr) | Dispositif de radiographie pour visualiser un objet d'examen et utilisation de ce dispositif de radiographie | |
DE102012217301A1 (de) | Kombination aus Kontrastmittel und Mammographie-CT-System mit vorgegebenem Energiebereich und Verfahren zur Erzeugung tomographischer Mammographie-CT-Aufnahmen durch diese Kombination | |
DE102005021068B4 (de) | Verfahren zur Voreinstellung der Aufnahmeparameter bei der Erstellung von zweidimensionalen Durchlicht-Röntgenaufnahmen | |
DE10141346A1 (de) | Verfahren zur Aufnahme von Messdaten mit einem Computertormographen | |
DE102012214472B4 (de) | Verfahren zur Ermittlung von Dualenergie-Bilddatensätzen und eine Röntgeneinrichtung dazu | |
EP0994729B1 (fr) | Utilisation d'agents de contraste intraveineux pour mammographie avec projection | |
EP3797698A1 (fr) | Procédé de génération d'un mammogramme synthétique se basant sur une imagerie par tomosynthèse double énergie | |
DE102005051490A1 (de) | Verfahren und Vorrichtung zur Verwendung von Tomographie zur Platzierung eines Instrumentes | |
DE102004006548B4 (de) | Verfahren zur Planung der Strahlentherapie eines Patienten und CT-System hierzu und zur Erstellung von CT-Aufnahmen | |
DE10347961A1 (de) | Röntgenanordnung und Röntgenkontrastverfahren zur Bildgebung an einem mindestens ein röntgenkontrastgebendes Element enthaltenden Untersuchungsobjekt sowie Verwendung der Röntgenanordnung | |
DE102006001655A1 (de) | Verfahren und Vorrichtung zur virtuellen Darmreinigung | |
EP4034175A1 (fr) | Représentation par images simultanées de deux zones fonctionnelles différentes | |
DE102020209714A1 (de) | Verfahren zur abschnittsweisen Aufnahme einer Röntgenaufnahme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20080421 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: FLOHR, THOMAS Inventor name: WEINMANN, HANNS-JOACHIM Inventor name: STIERSTORFER, KARL Inventor name: PIETSCH, HUBERTUS Inventor name: SUESS, CHRISTOPH Inventor name: GRASRUCK, MICHAEL |
|
17Q | First examination report despatched |
Effective date: 20100728 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BAYER PHARMA AKTIENGESELLSCHAFT Owner name: SIEMENS AKTIENGESELLSCHAFT |
|
DAX | Request for extension of the european patent (deleted) | ||
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: SIEMENS AKTIENGESELLSCHAFT Owner name: BAYER PHARMA AKTIENGESELLSCHAFT |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20150609 |